The effect of hemodialysis on right ventricular functions in patients with end-stage renal failure

被引:10
作者
Akkaya, Mehmet [1 ]
Erdogan, Ercan [2 ]
Sag, Saim [3 ]
Ari, Hasan [4 ]
Turker, Yasin [5 ]
Yilmaz, Mustafa [4 ]
机构
[1] Bursa Asker Hastanesi, Kardiyoloji Klin, Bursa, Turkey
[2] Bezmialem Univ, Tip Fak, Kardiyoloji Anabilim Dali, Istanbul, Turkey
[3] Gemlik Devlet Hastanesi, Kardiyoloji Klin, Bursa, Turkey
[4] Bursa Yuksek Ihtisas Egitim & Arastirma Hastanesi, Kardiyoloji Klin, Bursa, Turkey
[5] Gulkent Devlet Hastanesi, Kardiyoloji Klin, Isparta, Turkey
关键词
End stage renal failure; hemodialysis; echocardiography; right ventricle; diastolic function; MYOCARDIAL PERFORMANCE INDEX; TISSUE DOPPLER; DIASTOLIC FUNCTION; PRELOAD; ECHOCARDIOGRAPHY; REDUCTION;
D O I
10.5152/akd.2012.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study was to evaluate the effects of hemodialysis (HD) on right ventricular echocardiographic parameters in patients with end-stage renal failure (ESRF). Methods: Forty-three uremic patients who underwent echocardiography before and 30 minutes after dialysis included in this prospective observational study. Right ventricular systolic function was evaluated using tricuspid annular plane systolic excursion (TAPSE) by M-mode echocardiography and tricuspid lateral annular systolic velocity (Sal by tissue Doppler echocardiography whereas diastolic function was evaluated using tricuspid early (E) and late (A) diastolic flow velocities by conventional and tricuspid lateral annular early (Ea) and late (Aa) diastolic velocities by tissue Doppler echocardiography. Myocardial performance index was taken as an indicator of global functions. Paired t test or Wilcoxon test were used for statistical analysis where appropriate. Results: E decreased significantly (68 +/- 13 cm/s and 56 +/- 12 cm/s before and after HD, respectively; p<0.0001) but A did not (p=0.797).TAPSE was 1.84 +/- 0.34 cm before HD and showed a significant increase to 2.03 +/- 0.20 cm after HD (p=0.006). Right ventricular MPI, Sa and Aa did not change significantly by dialysis (p=0.504; p=0.118 and p=0.150 respectively) whereas Ea decreased to 8.8 +/- 2.5 cm/s from 11.3 +/- 3.4 cm/s (p<0.001). Ea/Aa ratio also decreased significantly to 0.69 +/- 0.35 from 0.84 +/- 0.44 with HD (p=0.007). Conclusion: The results of this study indicates that parameters of right ventricular systolic function such as Sa and MPI are independent of preload whereas the conventional and tissue Doppler parameters of right ventricular diastolic function are preload dependent in patients with end-stage renal failure who undergo regular hemodialysis. (Anadolu Kardiyol Derg 2012; 12: 5-10)
引用
收藏
页码:5 / 10
页数:6
相关论文
共 50 条
  • [41] Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis
    Cotoi, Laura
    Borcan, Florin
    Sporea, Ioan
    Amzar, Daniela
    Schiller, Oana
    Schiller, Adalbert
    Dehelean, Cristina A.
    Pop, Gheorghe Nicusor
    Borlea, Andreea
    Stoian, Dana
    DIAGNOSTICS, 2020, 10 (04)
  • [42] Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
    Kebria, Azar Shirzadian
    Aryanian, Zeinab
    Choobdar, Amin
    Akbari, Roghayeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 728 - 731
  • [43] Right ventricular protein expression profile in end-stage heart failure
    Su, Yan Ru
    Chiusa, Manuel
    Brittain, Evan
    Hemnes, Anna R.
    Absi, Tarek S.
    Lim, Chee Chew
    Di Salvo, Thomas G.
    PULMONARY CIRCULATION, 2015, 5 (03) : 481 - 497
  • [44] Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis
    Malik, Jan
    Lachmanova, Jana
    Kudlicka, Jaroslav
    Rocinova, Katarina
    Valerianova, Anna
    Bartkova, Magdalena
    Tesar, Vladimir
    NEPHRON, 2016, 133 (03) : 169 - 174
  • [45] Effect of hemodialysis on the metabolic clearance of 5-fluorouracil in a patient with end-stage renal failure
    Gusella, M
    Rebeschini, M
    Cartei, G
    Ferrazzi, E
    Ferrari, M
    Padrini, R
    THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 816 - 818
  • [46] Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis
    Averbukh, Z
    Berman, S
    Kishinevsky, E
    Feldman, L
    Cohn, M
    Rapoport, M
    Galperin, E
    Dishi, V
    Weissgarten, J
    JOURNAL OF NEPHROLOGY, 2004, 17 (01) : 101 - 106
  • [47] EFFECT OF LONG-TERM HEMODIALYSIS ON ARTERIAL COMPLIANCE IN END-STAGE RENAL-FAILURE
    BARENBROCK, M
    SPIEKER, C
    LASKE, V
    BAUMGART, P
    HOEKS, APG
    ZIDEK, W
    RAHN, KH
    NEPHRON, 1993, 65 (02): : 249 - 253
  • [48] Postoperative rhabdomyolysis in patients with end-stage renal failure
    Ori, Y
    Korzets, A
    Gruzman, C
    Chagnac, A
    Zevin, D
    Weinstein, T
    Herman, M
    Gafter, U
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (03) : 539 - 544
  • [49] Complementary use of peritoneal and hemodialysis: Therapeutic synergies in the treatment of end-stage renal failure patients
    Kawanishi, H.
    McIntyre, C.
    KIDNEY INTERNATIONAL, 2008, 73 : S63 - S67
  • [50] Mechanisms of Chronic Heart Failure Development in End-Stage Renal Disease Patients on Chronic Hemodialysis
    Malik, J.
    Tuka, V.
    Mokrejsova, M.
    Holaj, R.
    Tesar, V.
    PHYSIOLOGICAL RESEARCH, 2009, 58 (05) : 613 - 621